Form 4: Clearmind Medicine Inc. Insider Trading Activity

HRT FINANCIAL LP reports a transaction involving Clearmind Medicine Inc. common stock.

Summary

• HRT FINANCIAL LP, a 10% owner and director of Clearmind Medicine Inc., reported a transaction on June 12, 2026.
• The transaction involved the disposition of 2,102 shares of common stock at a price of $3.36 per share.
• Following this transaction, HRT FINANCIAL LP beneficially owns 106,675 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard insider transaction without additional context on the reasons for the sale or future intentions.

Negatives

• HRT FINANCIAL LP disposed of 2,102 shares of Clearmind Medicine Inc. common stock.

Future Outlook

No specific future outlook or guidance is provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for significant shareholders and insiders, providing transparency into their trading activities. This filing indicates a disposition of shares by a major holder and director.

Stakeholder Impact

• Shareholders may note the disposition of shares by a significant owner and director, which could be interpreted in various ways depending on broader market conditions and company performance.

Key Dates

Keywords

SEC Form 4, Insider Trading, Clearmind Medicine Inc., HRT FINANCIAL LP, Common Stock, Beneficial Ownership